United States Histone Deacetylase Inhibitors Market Report & Forecast 2021-2027

United States Histone Deacetylase Inhibitors Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Histone Deacetylase Inhibitors Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Histone Deacetylase Inhibitors Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Histone Deacetylase Inhibitors Overall Market Size
2.1 United States Histone Deacetylase Inhibitors Market Size: 2021 VS 2027
2.2 United States Histone Deacetylase Inhibitors Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Histone Deacetylase Inhibitors Sales: 2016-2027
3 Company Landscape
3.1 Top Histone Deacetylase Inhibitors Players in United States Market
3.2 Top United States Histone Deacetylase Inhibitors Companies Ranked by Revenue
3.3 United States Histone Deacetylase Inhibitors Revenue by Companies
3.4 United States Histone Deacetylase Inhibitors Sales by Companies
3.5 United States Histone Deacetylase Inhibitors Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Histone Deacetylase Inhibitors Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Histone Deacetylase Inhibitors Product Type
3.8 Tier 1, Tier 2 and Tier 3 Histone Deacetylase Inhibitors Players in United States Market
3.8.1 List of Tier 1 Histone Deacetylase Inhibitors Companies in United States
3.8.2 List of Tier 2 and Tier 3 Histone Deacetylase Inhibitors Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Histone Deacetylase Inhibitors Market Size Markets, 2021 & 2027
4.1.2 Belinostat
4.1.3 Romidepsin
4.1.4 Chidamide
4.2 By Type - United States Histone Deacetylase Inhibitors Revenue & Forecasts
4.2.1 By Type - United States Histone Deacetylase Inhibitors Revenue, 2016-2021
4.2.2 By Type - United States Histone Deacetylase Inhibitors Revenue, 2022-2027
4.2.3 By Type - United States Histone Deacetylase Inhibitors Revenue Market Share, 2016-2027
4.3 By Type - United States Histone Deacetylase Inhibitors Sales & Forecasts
4.3.1 By Type - United States Histone Deacetylase Inhibitors Sales, 2016-2021
4.3.2 By Type - United States Histone Deacetylase Inhibitors Sales, 2022-2027
4.3.3 By Type - United States Histone Deacetylase Inhibitors Sales Market Share, 2016-2027
4.4 By Type - United States Histone Deacetylase Inhibitors Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Histone Deacetylase Inhibitors Market Size, 2021 & 2027
5.1.2 Cancer Treatment
5.1.3 Inflammatory Diseases
5.1.4 Other Diseases
5.2 By Application - United States Histone Deacetylase Inhibitors Revenue & Forecasts
5.2.1 By Application - United States Histone Deacetylase Inhibitors Revenue, 2016-2021
5.2.2 By Application - United States Histone Deacetylase Inhibitors Revenue, 2022-2027
5.2.3 By Application - United States Histone Deacetylase Inhibitors Revenue Market Share, 2016-2027
5.3 By Application - United States Histone Deacetylase Inhibitors Sales & Forecasts
5.3.1 By Application - United States Histone Deacetylase Inhibitors Sales, 2016-2021
5.3.2 By Application - United States Histone Deacetylase Inhibitors Sales, 2022-2027
5.3.3 By Application - United States Histone Deacetylase Inhibitors Sales Market Share, 2016-2027
5.4 By Application - United States Histone Deacetylase Inhibitors Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Acetylon Pharmaceuticals
6.1.1 Acetylon Pharmaceuticals Corporation Information
6.1.2 Acetylon Pharmaceuticals Overview
6.1.3 Acetylon Pharmaceuticals Histone Deacetylase Inhibitors Sales and Revenue in United States Market (2016-2021)
6.1.4 Acetylon Pharmaceuticals Histone Deacetylase Inhibitors Product Description
6.1.5 Acetylon Pharmaceuticals Recent Developments
6.2 Shenzhen Chipscreen Biosciences
6.2.1 Shenzhen Chipscreen Biosciences Corporation Information
6.2.2 Shenzhen Chipscreen Biosciences Overview
6.2.3 Shenzhen Chipscreen Biosciences Histone Deacetylase Inhibitors Sales and Revenue in United States Market (2016-2021)
6.2.4 Shenzhen Chipscreen Biosciences Histone Deacetylase Inhibitors Product Description
6.2.5 Shenzhen Chipscreen Biosciences Recent Developments
6.3 Spectrum Pharmaceuticals
6.3.1 Spectrum Pharmaceuticals Corporation Information
6.3.2 Spectrum Pharmaceuticals Overview
6.3.3 Spectrum Pharmaceuticals Histone Deacetylase Inhibitors Sales and Revenue in United States Market (2016-2021)
6.3.4 Spectrum Pharmaceuticals Histone Deacetylase Inhibitors Product Description
6.3.5 Spectrum Pharmaceuticals Recent Developments
6.4 Adooq Bioscience
6.4.1 Adooq Bioscience Corporation Information
6.4.2 Adooq Bioscience Overview
6.4.3 Adooq Bioscience Histone Deacetylase Inhibitors Sales and Revenue in United States Market (2016-2021)
6.4.4 Adooq Bioscience Histone Deacetylase Inhibitors Product Description
6.4.5 Adooq Bioscience Recent Developments
6.5 Crystal Genomics
6.5.1 Crystal Genomics Corporation Information
6.5.2 Crystal Genomics Overview
6.5.3 Crystal Genomics Histone Deacetylase Inhibitors Sales and Revenue in United States Market (2016-2021)
6.5.4 Crystal Genomics Histone Deacetylase Inhibitors Product Description
6.5.5 Crystal Genomics Recent Developments
7 United States Histone Deacetylase Inhibitors Production Capacity, Analysis
7.1 United States Histone Deacetylase Inhibitors Production Capacity, 2016-2027
7.2 Histone Deacetylase Inhibitors Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Histone Deacetylase Inhibitors Supply Chain Analysis
9.1 Histone Deacetylase Inhibitors Industry Value Chain
9.2 Histone Deacetylase Inhibitors Upstream Market
9.3 Histone Deacetylase Inhibitors Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Histone Deacetylase Inhibitors Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Histone Deacetylase Inhibitors in United States Market
Table 2. Top Histone Deacetylase Inhibitors Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Histone Deacetylase Inhibitors Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Histone Deacetylase Inhibitors Revenue Share by Companies, 2016-2021
Table 5. United States Histone Deacetylase Inhibitors Sales by Companies, (Doses), 2016-2021
Table 6. United States Histone Deacetylase Inhibitors Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Histone Deacetylase Inhibitors Price (2016-2021) & (USD/Dose)
Table 8. Manufacturers Histone Deacetylase Inhibitors Product Type
Table 9. List of Tier 1 Histone Deacetylase Inhibitors Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Histone Deacetylase Inhibitors Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Belinostat
Table 12. Major Manufacturers of Romidepsin
Table 13. By Type - United States Histone Deacetylase Inhibitors Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Histone Deacetylase Inhibitors Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Histone Deacetylase Inhibitors Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Histone Deacetylase Inhibitors Sales (Doses), 2016-2021
Table 17. By Type - United States Histone Deacetylase Inhibitors Sales (Doses), 2022-2027
Table 18. By Application - United States Histone Deacetylase Inhibitors Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Histone Deacetylase Inhibitors Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Histone Deacetylase Inhibitors Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Histone Deacetylase Inhibitors Sales (Doses), 2016-2021
Table 22. By Application - United States Histone Deacetylase Inhibitors Sales (Doses), 2022-2027
Table 23. Acetylon Pharmaceuticals Corporation Information
Table 24. Acetylon Pharmaceuticals Description and Major Businesses
Table 25. Acetylon Pharmaceuticals Histone Deacetylase Inhibitors Sales (Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 26. Acetylon Pharmaceuticals Histone Deacetylase Inhibitors Product
Table 27. Acetylon Pharmaceuticals Recent Developments
Table 28. Shenzhen Chipscreen Biosciences Corporation Information
Table 29. Shenzhen Chipscreen Biosciences Description and Major Businesses
Table 30. Shenzhen Chipscreen Biosciences Histone Deacetylase Inhibitors Sales (Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 31. Shenzhen Chipscreen Biosciences Histone Deacetylase Inhibitors Product
Table 32. Shenzhen Chipscreen Biosciences Recent Developments
Table 33. Spectrum Pharmaceuticals Corporation Information
Table 34. Spectrum Pharmaceuticals Description and Major Businesses
Table 35. Spectrum Pharmaceuticals Histone Deacetylase Inhibitors Sales (Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 36. Spectrum Pharmaceuticals Histone Deacetylase Inhibitors Product
Table 37. Spectrum Pharmaceuticals Recent Developments
Table 38. Adooq Bioscience Corporation Information
Table 39. Adooq Bioscience Description and Major Businesses
Table 40. Adooq Bioscience Histone Deacetylase Inhibitors Sales (Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 41. Adooq Bioscience Histone Deacetylase Inhibitors Product
Table 42. Adooq Bioscience Recent Developments
Table 43. Crystal Genomics Corporation Information
Table 44. Crystal Genomics Description and Major Businesses
Table 45. Crystal Genomics Histone Deacetylase Inhibitors Sales (Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 46. Crystal Genomics Histone Deacetylase Inhibitors Product
Table 47. Crystal Genomics Recent Developments
Table 48. Histone Deacetylase Inhibitors Production Capacity (Doses) of Key Manufacturers in United States Market, 2019-2021 (Doses)
Table 49. United States Histone Deacetylase Inhibitors Capacity Market Share of Key Manufacturers, 2019-2021
Table 50. Histone Deacetylase Inhibitors Market Opportunities & Trends in United States Market
Table 51. Histone Deacetylase Inhibitors Market Drivers in United States Market
Table 52. Histone Deacetylase Inhibitors Market Restraints in United States Market
Table 53. Histone Deacetylase Inhibitors Raw Materials
Table 54. Histone Deacetylase Inhibitors Raw Materials Suppliers in United States Market
Table 55. Typical Histone Deacetylase Inhibitors Downstream
Table 56. Histone Deacetylase Inhibitors Downstream Clients in United States Market
Table 57. Histone Deacetylase Inhibitors Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Histone Deacetylase Inhibitors Product Picture
Figure 2. Histone Deacetylase Inhibitors Segment by Type
Figure 3. Histone Deacetylase Inhibitors Segment by Application
Figure 4. United States Histone Deacetylase Inhibitors Market Overview: 2020
Figure 5. United States Histone Deacetylase Inhibitors Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Histone Deacetylase Inhibitors Revenue, 2016-2027 (US$, Mn)
Figure 7. Histone Deacetylase Inhibitors Sales in United States Market: 2016-2027 (Doses)
Figure 8. The Top 3 and 5 Players Market Share by Histone Deacetylase Inhibitors Revenue in 2020
Figure 9. Belinostat Product Picture
Figure 10. Romidepsin Product Picture
Figure 11. Chidamide Product Picture
Figure 12. By Type - United States Histone Deacetylase Inhibitors Sales Market Share, 2016-2027
Figure 13. By Type - United States Histone Deacetylase Inhibitors Revenue Market Share, 2016-2027
Figure 14. By Type - United States Histone Deacetylase Inhibitors Price (USD/Dose), 2016-2027
Figure 15. Cancer Treatment
Figure 16. Inflammatory Diseases
Figure 17. Other Diseases
Figure 18. By Application - United States Histone Deacetylase Inhibitors Sales Market Share, 2016-2027
Figure 19. By Application - United States Histone Deacetylase Inhibitors Revenue Market Share, 2016-2027
Figure 20. By Application - United States Histone Deacetylase Inhibitors Price (USD/Dose), 2016-2027
Figure 21. Acetylon Pharmaceuticals Histone Deacetylase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Shenzhen Chipscreen Biosciences Histone Deacetylase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Spectrum Pharmaceuticals Histone Deacetylase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Adooq Bioscience Histone Deacetylase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Crystal Genomics Histone Deacetylase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. United States Histone Deacetylase Inhibitors Production Capacity (Doses), 2016-2027
Figure 27. Histone Deacetylase Inhibitors Industry Value Chain
Figure 28. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs